COMMUNIQUÉS West-GlobeNewswire

MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP
27/08/2018
Hoersholm, Denmark, August 27, 2018 - Medical Prognosis Institute A/S and Oncology Venture AB (OV:ST) ("OV" or the "Company") and Oncology Venture US Inc today announced that the US Food and Drug Administration (FDA) [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
27/08/2018
Villepinte (France), le 27 août 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur la [...]
Misonix to Report Fiscal 2018 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 5
27/08/2018
FARMINGDALE, N.Y., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Biohit Oyj: Managers' Transactions
27/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 27 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: [...]
Biohit Oyj: Managers' Transactions
27/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer: Biohit Oyj LEI: [...]
Sienna Biopharmaceuticals Announces Results from First-in-Human Study of SNA-125 in Psoriasis and Continued Progression to Phase 2
27/08/2018
-- Phase 1/2 study data of SNA-125 in atopic dermatitis on track to be released in fourth quarter of 2018 -- SNA-125 Phase 2 studies expected to begin in second half of 2019 WESTLAKE VILLAGE, Calif., Aug. 27, 2018 ( [...]
Obalon Therapeutics Announces Closing of $10 Million Private Placement
27/08/2018
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Delcath Announces Acceptance of Abstract for Poster Presentation at CIRSE 2018
27/08/2018
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a [...]
Naturally Splendid Increases Vertical Integration and Expands International Footprint -- CFN Media
27/08/2018
SEATTLE, Aug. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Lexington Announces Non-Brokered Private Placement
27/08/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE [...]
AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics
27/08/2018
AXIM Partners with REVIVE to Begin Selling Its Leading Cannabidiol-Containing Nutraceutical Product in Canada NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech or the “Company” ) ( [...]
Scythian Biosciences Closes Acquisition of MMJ Colombia Partners
27/08/2018
Closing of Colombia Acquisition is Key Benchmark in Finalization of Previously Announced $193 Million Sale of Assets in Latin America, Which As Of Friday’s Close Was Valued At More than $219 Million TORONTO, Aug. 27, [...]
Solon Eiendom ASA – Primary insider notification
27/08/2018
(Oslo, Norway, 27 August 2018) Per Knut Asphaug Bernhardt, PA to the chairman of the board of Solon Eiendom ASA, has today rolled over two forward contracts for a total of 124,375 shares in Solon Eiendom ASA. Through [...]
Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development
27/08/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]
Novo Nordisk A/S - Share repurchase programme
27/08/2018
Bagsværd, Denmark, 27 August 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
NRC Health Releases First Loyalty-Based U.S. Hospital Rankings
27/08/2018
Largest online consumer healthcare survey reveals top hospitals in consumer loyalty, according to more than 300,000 U.S. consumers LINCOLN, Neb., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in [...]
BioCanCell Announces Company Name Change to Anchiano Therapeutics
27/08/2018
CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced [...]
Assure Holdings to Present at the 7th Annual Liolios Gateway Conference on September 5, 2018
27/08/2018
DENVER, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 7 th Annual [...]
Rhinogram Announces Appointment of New President to Guide Expansion into Medical Practice Market
27/08/2018
Company also adds chief technology officer to drive company’s technology architecture CHATTANOOGA, Tenn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rhinogram , a leader in cloud-based, HIPAA-compliant, telehealth communications [...]

Pages